Effects of dietary phytosterols on cholesterol metabolism and atherosclerosis: Clinical and experimental evidence

American Journal of Medicine

Volumn 107, Issue 6, 1999, Pages 588-594

  Moghadasian, Mohammed H ^a   Frohlich, Jiri J ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPESTEROL; CHOLESTEROL; COLESTIPOL; COLESTYRAMINE; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PHYTOSTEROL; SITOSTANOL; STIGMASTEROL;

ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; DIET; DRUG EFFECT; DYSLIPIDEMIA; HUMAN; HYPERCHOLESTEROLEMIA; LIPID METABOLISM; PRIORITY JOURNAL; REVIEW;

ANTICHOLESTEREMIC AGENTS; ARTERIOSCLEROSIS; CHOLESTEROL; CHOLESTYRAMINE; HUMANS; INTESTINAL ABSORPTION; PHYTOSTEROLS; SITOSTEROLS;

EID: 0032763577     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00285-5     Document Type: Review

References (86)

1. Weihrauch J.L., Gardner J.M. Sterol content of foods of plant origin. J Am Diet Assoc. 73:1978;39-47.
2. Connor W.E. Dietary sterols their relationship to atherosclerosis . J Am Diet Assoc. 52:1968;202-208.
3. Hirai K., Shimazu C., Takezoe R., Ozeki Y. Cholesterol, phytosterol and polyunsaturated fatty acid levels in 1982 and 1957 Japanese diets. J Nutr Sci Vitaminol. 32:1986;363-372.
4. Subbiah M.T. Significance of dietary plant sterols in man and experimental animals. Mayo Clin Proc. 46:1971;549-559.
5. Salen G., Kwiterovich Po Jr, Shefer S., et al. Increased plasma cholesterol and 5alpha-saturated plant sterol derivatives in subjects with sitosterolemia and xanthomatosis. J Lipid Res. 26:1985;203-209.
6. Hendriks H.F.J., Weststrate J.A., van Vliet T., Meijer G.W. Spreads enriched with three different levels of vegetable oil sterols and the degree of cholesterol lowering in normocholesterolemic and mildly hypercholesterolemic subjects. Eur J Clin Nutr. 53:1999;319-327.
7. Hallikainen M.A., Uusitupa M.I. Effects of 2 low-fat stanol ester-containing margarines on serum cholesterol concentrations as part of a low-fat diet in hypercholesterolemic subjects. Am J Clin Nutr. 69:1999;403-410.
8. Gylling H., Miettinen T.A. Cholesterol reduction by different plant stanol mixtures and with variable fat intake. Metabolism. 48:1999;575-580.
9. Jones P.J.H., Ntanios F.Y., Raeini-Sarjaz M., Vanstone C.A. Cholesterol-lowering efficacy of a sitostanol-containing phytosterol mixture with a prudent diet in hyperlipidemic men. Am J Clin Nutr. 69:1999;1144-1150.
10. Weststrate J.A., Meijer G.W. Plant sterol-enriched margarines and reduction of plasma total- and LDL-cholesterol concentrations in normocholesterolemic and mildly hypercholesterolemic subjects. Eur J Clin Nutr. 52:1998;334-343.
11. Jones P.J., Howell T., MacDougall D.E., et al. Short-term administration of tall oil phytosterols improves plasma lipid profiles in subjects with different cholesterol levels. Metabolism. 47:1998;751-756.
12. Gylling H., Radhakrishnan R., Miettinen T.A. Reduction of serum cholesterol in postmenopausal women with previous myocardial infarction and cholesterol malabsorption induced by dietary sitostanol ester margarine women and dietary sitostanol . Circulation. 96:1997;4226-4231.
13. Gylling H., Miettinen T.A. Effects of inhibiting cholesterol absorption and synthesis on cholesterol and lipoprotein metabolism in hypercholesterollemic non-insulin dependent diabetic men. J Lipid Res. 37:1996;1776-1785.
14. Miettinen T.A., Puska P., Gllying H., et al. Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. NEJM. 333:1995;1308-1312.
15. Gylling H., Siimes M.A., Miettinen T.A. Sitostanol ester margarine in dietary treatment of children with familial hypercholesterolemia. J Lipid Res. 36:1995;1807-1812.
16. Vanhanen H.T., Kajander J., Lehtovirta H., Miettinen T.A. Serum levels, absorption efficacy, fecal elimination and synthesis of cholesterol during increasing doses of dietary sitostanol esters in hypercholesterolemic subjects. Clin Sci. 87:1994;61-67.
17. Denke M.A. Lack of efficacy of low-dose sitostanol therapy as an adjunct to a cholesterol-lowering diet in men with moderate hypercholesterolemia. Am J Clin Nutr. 61:1994;392-396.
18. Gylling H., Miettinen T.A. Serum cholesterol and cholesterol and lipoprotein metabolism in hypercholesterolemic NIDDM patients before and during sitostanol ester-margarine treatment. Diabetologia. 37:1994;773-780.
19. Becker M., Staab D., Von Bergmann K. Treatment of severe familial hypercholesterolemia in childhood with sitosterol and sitostanol. J Pediatr. 122:1993;292-296.
20. Vanhanen H.T., Blomqvist S., Ehnholm C., et al. Serum cholesterol, cholesterol precursors, and plant sterols in hypercholesterolemic subjects with different apo E phynotypes during dietary sitostanol ester treatment. J Lipid Res. 34:1993;1535-1544.
21. Becker M., Staab D., Von Bergmann K. Long-term treatment of severe familial hypercholesterolemia in children effects of sitosterol and bezafibrate . Pediatrics. 89:1992;138-142.
22. Peterson D.W. Effect of soybean sterols in the diet on plasma and liver cholesterol in chicks. Proc Soc Biol Med. 78:1951;143-147.
23. Moghadasian M.H., McManus B.M., Pritchard P.H., Frohlich J.J. "Tall-oil"-derived phytosterols reduce atherosclerosis in apo E-deficient mice. Arterioscler Thromb Vasc Biol. 17:1997;119-126.
24. Moghadasian M.H., McManus B.M., Godin D.V., et al. Pro-atherogenic and anti-atherogenic effects of probucol and phytosterols in apo E-deficient mice possible mechanisms of action . Circulation. 99:1999;1733-1739.
25. Moghadasian M.H., Nguyen L.B., Shefer S., et al. Histologic, hematologic, and biochemical characteristics of apo E-deficient mice effects of dietary cholesterol and phytosterols . Lab Invest. 79:1999;355-364.
26. Moghadasian M.H., Godin D.V., McManus B.M., Frohlich J.J. Lack of regression of atherosclerotic lesions in phytosterol-treated apo E-deficient mice. Life Sci. 64:1999;1029-1036.
27. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease the Scandinavian Simvastatin Survival Study (4S) . Lancet. 344:1994;1383-1389.
28. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The long-term intervention with pravastatin in ischemic disease (LIPID) study group. NEJM 1998;339:1349-1357.
29. Salen G., Ahrens E.H. Jr, Grundy S.M. Metabolism of beta-sitosterol in man. J Clin Invest. 49:1970;952-967.
30. Gould R.G., Jones R.J., LeRoy G.V., et al. Absorbability of beta-sitosterol in humans. Metabolism. 18:1969;652-662.
31. Bhattacharyya A., Connor W.E. β-Sitosterolemia and xanthomatosis. A newly described lipid storage disease in two sisters. J Clin Invest. 53:1974;1033-1043.
32. Miettinen T.A. Phytosterolemia, xanthomatosis and premature atherosclerotic arterial disease a case with high plant sterol absorption, impaired sterol elimination and low cholesterol synthesis . Eur J Clin Invest. 10:1980;27-35.
33. Shefer S., Salen G., Bullock J., et al. The effect of increased hepatic sitosterol on the regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase and cholesterol 7 α-hydroxylase in the rat and sitosterolemic homozygotes. Hepatology. 20:1994;213-219.
34. Heinemann T., Axtmann G., von Bergmann K. Comparison of intestinal absorption of cholesterol with different plant sterols in man. Eur J Clin Invest. 23:1993;827-831.
35. Subbiah M.T., Kottke B.A., Carlo I.A. Experimental studies in the spontaneous-atherosclerosis-susceptible white Carneau pigeon nature of biliary and fecal neutral steroids . Mayo Clin Proc. 45:1970;729-737.
36. Sugano M., Morioka H., Kida Y., Ikeda I. The distribution of dietary plant sterols in serum lipoproteins and liver subcellular fractions of rats. Lipids. 13:1978;427-432.
37. Kuksis A., Huang T.C. Differential absorption of plant sterols in the dog. Can J Biochem Physiol. 40:1962;1493-1504.
38. Boberg K.M., Skrede S. Content of sitosterol, cholestanol, and cholesterol in very low density lipoproteins of rat liver perfusate. Scand J Gastroenterol. 23:1988;442-448.
39. Vahouny G.V., Connor W.E., Subramaniam S., et al. Comparative lymphatic absorption of sitosterol, stigmasterol and fucosterol and differential inhibition of cholesterol absorption. Am J Clin Nutr. 37:1983;805-809.
40. Dobiasova M. Lecithin cholesterol acyltransferase and the regulation of endogenous cholesterol transport . Adv Lipid Res. 20:1983;107-192.
41. Subbiah M.T., Kottke B.A., Carlo I.A., Naylor M.C. Human intestinal specificity toward dietary sterols studied by balance methods. Nutr Metabol. 18:1975;23-30.
42. McNamara D.J., Proia A., Miettinen T.A. Thin-layer and gas-liquid chromatographic identification of neutral steroids in human and rat feces. J Lipid Res. 22:1981;474-484.
43. Eneroth P., Hellstrom K., Ryhage R. Identification and quantification of neutral fecal steroids by gas chromatography and mass spectrometry studies of human excretion during two dietary regimens . J Lipid Res. 5:1964;245-262.
44. Slota T., Kozlov N.A., Ammon H.V. Comparison of cholesterol and sitosterol effects on jejunal fluid secretion induced by oleate and absorption from mixed micellar solutions . Gut. 24:1983;653-658.
45. Ikeda I., Tanaka K., Sugano M., et al. Inhibition of cholesterol absorption in rats by plant sterols. J Lipid Res. 29:1988;1573-1582.
46. Borgstrom B. Quantitative aspects of the intestinal absorption and metabolism of cholesterol and sitosterol in the rat. J Lipid Res. 9:1968;473-481.
47. Child P., Kuksis A. Uptake of 7-dehydro derivatives of cholesterol, campesterol and sitosterol by rat erythrocytes, jejunal villus cells and brush border membranes. J Lipid Res. 24:1983;552-565.
48. 2 . Agri Biol Chem. 54:1990;2646-2654.
49. Ikeda I., Tanaka K., Sugano M., et al. Discrimination between cholesterol and sitosterol for absorption in rats. J Lipid Res. 29:1988;1583-1591.
50. 14-phytosterols. Proc Soc Exp Biol Med. 108:1961;810-813.
51. Boberg K.M., Skrede B., Skrede S. Metabolism of 24-ethyl-4-cholesten-3-one and 24-ethyl-5-cholesten-3-β-ol (sitosterol) after intraperitoneal injection in the rat. Scand J Clin Lab Invest. 46:(suppl 84):1986;47-54.
52. Subbiah M.T., Kuksis A. Differences in metabolism of cholesterol and sitosterol following intravenous injection in rats. Biochim Biophys Acta. 306:1973;95-105.
53. Subbiah M.T., Kuksis A. Conversion of β-sitosterol to steroid hormones in rat testes in vitro. Experientia. 31:1975;763-764.
54. 14C-β-sitosterol by mitochondria of rat liver and testes. Fed Proc 1969;28:515. Abstract.
55. 3-β-sitosterol in the guinea pig its conversion to urinary cortisol . J Biol Chem. 235:1960;1629-1633.
56. Aringer L., Eneroth P., Nordstrom L. Side-chain cleavage of 4-cholesten-3-one, 5-cholesten-3α-ol, β-sitosterol and related steroids in endocrine tissues from rat and man. J Steroid Biochem. 11:1979;1271-1285.
57. Gerson T., Shorland F.B., Dunckley G.G. The effects of sitosterol on the metabolism of cholesterol and lipids in rats on a diet low in fat. Biochem J. 92:1964;385-390.
58. Konlande J.E., Fisher H. Evidence for a nonabsorptive antihypercholesterolemic action of phytosterols in the chicken. J Nutr. 98:1969;435-442.
59. Laraki L., Pelletier X., Mourot J., Debry G. Effects of dietary phytosterols on liver lipids and lipid metabolism enzymes. Ann Nutr Metab. 37:1993;129-133.
60. Nguyen L., Salen G., Shefer S., et al. Deficient ileal 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in sitosterolemia sitosterol is not a feedback inhibitor of intestinal cholesterol biosynthesis . Metabolism. 43:1994;855-859.
61. Moghadasian M.H. Effects of a "tall oil"-derived phytosterol mixture on the development of atherosclerotic lesions in apo E-deficient mice. PhD thesis. 1998;University of British Columbia, Vancouver, BC.
62. Shefer S., Hauser S., Lapar V., Mosbach E.H. Regulatory effects of sterols and bile acids on hepatic 3-hydroxy-3-methyglutaryl CoA reductase and cholesterol 7 α-hydroxylase in the rat. J Lipid Res. 14:1973;573-580.
63. Weisweller P., Heinemann V., Schwandt P. Serum lipoproteins and lecithin:cholesterol acyltransferase (LCAT) activity in hypercholesterolemic subjects given β-sitosterol. Int J Clin Pharmacol. 22:1984;204-206.
64. Aviram M., Eias K. Dietary olive oil reduces low-density lipoprotein uptake by macrophages and decreases the susceptibility of the lipoprotein to undergo lipid peroxidation. Ann Nutr Metab. 37:1993;75-84.
65. Bhadra S., Subbiah M.T. Incorporation of liposomal phytosterols into human cells in culture a potential in vitro model for investigating pathological effects of phytosterolemia . Biochem Med Met Biol. 46:1991;119-124.
66. Field F.J., Born E., Satya N.M. Effects of micellar sitosterol on cholesterol metabolism in CaCo-2 cells. J Lipid Res. 38:1997;348-360.
67. Nair P.P., Turjman N., Kessie G., et al. Diet, nutrition intake, and metabolism in populations at high and low risk for colon cancer. Dietary cholesterol, sitosterol and stigmasterol. Am J Clin Nutr. 40:1984;927-930.
68. Carbin B.E., Larsson B., Lindahl O. Treatment of benign prostatic hyperplasia with phytosterols. Br J Urol. 66:1990;639-641.
69. Klippel K.F., Hiltl D.M., Schipp B. A multicentric, placebo-controlled, double-blind clinical trial of β-sitosterol (phytosterol) for the treatment of benign prostatic hyperplacia. Br J Urol. 80:1997;427-432.
70. Sharma O.P., Adlercreutz H., Strandberg J.D., et al. Soy of dietary source plays a preventative role against the pathogenesis of prostatitis in rats. J Steroid Biochem Mol Biol. 43:1992;557-564.
71. Wang C., Lin H.J., Chan T.K., et al. A unique patient with coexisting cerebrotendinous xanthomatosis and sitosterolemia. Am J Med. 71:1981;313-319.
72. Leikin A.I., Brenner R.I. Fatty acid desaturase activities are modulated by phytosterol incorporation in microsomes. Biochim Biophys Acta. 1005:1989;187-191.
73. Boberg K., Pettersen K.S., Prydz H. Toxicity of sitosterol to human umbilical vein endothelial cells in vitro. Scand J Clin Lab Invest. 51:1991;509-516.
74. Malini T., Vanithakumari G. Antifertility of β-sitosterol in male albino rats. J Ethnopharmacol. 35:1991;149-153.
75. Whittaker M.H., Frankos V.H., Wolterbreek A.P.M., Waalkens-Berendsen D.H. Two-generation reproductive toxicity study of plant stanol esters in rats. Regul Toxicol Pharmacol. 29:1999;196-204.
76. Kwiterovich P.O. Jr, Smith H.H., Connor W.E., et al. Hyperapobetalipoproteinemia in two families with xanthomatosis and phytosterolemia. Lancet. 1:1981;466-469.
77. Salen G., Horak I., Rothkopf M., et al. Lethal atherosclerosis associated with abnormal plasma and tissue sterol composition in sitosterolemia with xanthomatosis. J Lipid Res. 26:1985;1126-1133.
78. Nguyen L., Shefer S., Salen G., et al. Molecular defect in cholesterol synthesis in sitosterolemia with xanthomatosis. J Clin Invest. 86:1990;926-931.
79. Parsons H.G., Jamal R., Baylis B., et al. A marked and sustained reduction in LDL sterols by diet and cholestyramine in β-sitosterolemia. Clin Invest Med. 18:1995;389-400.
80. Nguyen L.B., Cobb M., Shefer S., et al. Regulation of cholesterol biosynthesis in sitosterolemia effects of lovastatin, cholestyramine and dietary sterol restriction . J Lipid Res. 32:1991;1941-1948.
81. Cobb M.M., Salen G., Tint G.S., et al. Sitosterolemia opposing effects of cholestyramine and lovastatin on plasma sterol levels in a homozygous girl and her heterozygous father . Metabolism. 45:1996;673-679.
82. Belamarich P.F., Deckelbaum R.J., Starc T.J., et al. Response to diet and cholestyramine in a patient with sitosterolemia. Pediatrics. 86:1990;977-981.
83. Hidaka H., Nakamura T., Aoki T., et al. Increased plasma plant sterol levels in heterozygotes with sitosterolemia and xanthomatosis. J Lipid Res. 31:1990;881-888.
84. Nguyen L.B., Shefer S., Salen G., et al. Competitive inhibition of hepatic 27-hydroxylase by sitosterol decreased activity in sitosterolemia . Proc Assoc Am Phys. 110:1998;32-39.
85. Salen G., Shefer S., Nguyen L., et al. Sitosterolemia. J Lipid Res. 33:1992;945-955.
86. Macilwain C. US panel split on endocrine disruptors. Nature. 395:1998;828.